HSIF02 · House Subcommittee

Oversight and Investigations Subcommittee

Under Energy and Commerce Committee energycommerce.house.gov

House Energy and Commerce Subcommittee on Oversight and Investigations

Showing the 114th Congress (2015–2016). Back to the 119th Congress

0 bills referred in the 114th Congress

1 across the 1 Congress on file, most in the 111th at 1. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 111th to 111th

Members

Served in the 114th Congress

Meetings

Hearings and business meetings in the 114th Congress

Members, 114th Congress 24

Everyone listed on the subcommittee in the 114th Congress, from printed hearings, the Congressional Directory and the official rosters.

Seat	Member	Role
R-PA	Tim Murphy	Chair
D-CO	Diana DeGette	Ranking Member
R-WV	David B. McKinley	Vice Chair
D-NJ	Frank Pallone, Jr.	Ex Officio
R-MI	Fred Upton	Ex Officio
R-TX	Bill Flores
R-NY	Chris Collins
D-TX	Gene Green
R-VA	H. Morgan Griffith
D-IL	Janice D. Schakowsky
R-TX	Joe Barton
D-KY	John A. Yarmuth
D-MA	Joseph P. Kennedy III
D-FL	Kathy Castor
R-ND	Kevin Cramer
R-IN	Larry Bucshon
R-OK	Markwayne Mullin
R-TN	Marsha Blackburn
R-TX	Michael C. Burgess
D-NY	Paul Tonko
D-VT	Peter Welch
R-NC	Richard Hudson
R-IN	Susan W. Brooks
D-NY	Yvette D. Clarke

Record

Bills, meetings, hearings, reports and more, newest first. In the 114th Congress.

Hearings, markups and business meetings, newest first. In the 114th Congress.

Kind	Subject	Status	Date
Hearing	Volkswagen’s Emissions Cheating Settlement: Questions Concerning ZEV Program ImplementationRayburn House Office Building 232225 documents 2 witnesses Cynthia Giles, Assistant Administrator, Office of Enforcement and Compliance Assurance, U.S. Environmental Protection Agency Janet McCabe, Acting Assistant Administrator, Office of Air and Radiation, U.S. Environmental Protection Agency	Rescheduled	Dec 6, 2016

Hearing	Bioresearch Labs and Inactivation of Dangerous PathogensRayburn House Office Building 232230 documents 6 witnesses Dr. Timothy Persons, Chief Scientist, U.S. Government Accountability Office Dr. Daniel Sosin, Deputy Director and Chief Medical Officer, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention Dr. Steve Monroe, Associate Director for Laboratory Science and Safety, Centers for Disease Control and Prevention Dr. Mark Davidson, Associate Deputy Administrator, Veterinary Services, U.S. Department of Agriculture Mr. Jeff Potts, BioRisk Manager, National Institutes of Health Major General Barbara Holcomb, Commanding General, U.S. Army Medical Research and Materiel Command and Fort Detrick, MD, Deputy for Medical Systems to the Assistant Secretary of the Army for Acquisition, Logistics, and Technology; and Chief, U.S. Army Nurse Corps	Rescheduled	Sep 27, 2016

Hearing	The ACA’s Cost Sharing Reduction Program: Ramifications of the Administration’s Decision on the Source of Funding for the CSR ProgramRayburn House Office Building 232210 documents 4 witnesses Mr. Doug Badger, Senior Fellow, Galen Institute Mr. Tom Miller, Resident Fellow, American Enterprise Institute Mr. Morton Rosenberg, Legislative Consultant Mr. Simon Lazarus, Senior Counsel, The Constitutional Accountability Center	Scheduled	Jul 8, 2016

Hearing	How Secure are U.S. Bioresearch Labs? Preventing the Next Safety Lapse.Rayburn House Office Building 232243 documents 5 witnesses Mr. John Neumann, Director, Government Accountability Office Dr. Lawrence Tabak, Principal Deputy Director, National Institutes of Health Dr. Steve Monroe, Associate Director for Laboratory Science and Safety, Centers for Disease Control and Prevention Dr. Segaran Pillai, Director, U.S. Food and Drug Administration Major General Brian Lein, Commanding General, U.S. Department of Defense	Scheduled	Apr 20, 2016

Hearing	Examining the U.S. Public Health Response to the Zika VirusRayburn House Office Building 232231 documents 9 witnesses Mr. Joseph Conlon, Technical Advisor, American Mosquito Control Association Mr. Lawrence Gostin, Faculty Director, O'Neill Institute for National and Global Health Law, Georgetown University Law Center Dr. Peter Hotez, Dean, National School of Tropical Medicine, Texas Children's Hospital Dr. Jeanne Sheffield, Director of the Division of Maternal-Fetal Medicine, Johns Hopkins University School of Medicine Dr. Luciana Borio, Assistant Commissioner for Counterterrorism Policy, U.S. Food and Drug Administration Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health Dr. Thomas Frieden, Director, Centers for Disease Control and Prevention Dr. Nicole Lurie, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services Dr. Timothy Persons, Chief Scientist, U.S. Government Accountability Office	Scheduled	Mar 2, 2016

Hearing	DOE for the 21st Century: Science, Environment, and National Security MissionsRayburn House Office Building 232237 documents 4 witnesses The Honorable Norman Augustine, Co-Chairman, Congressional Advisory Panel on the Governance of the Nuclear Security Enterprise Admiral Richard Mies, Co-Chairman, Congressional Advisory Panel on the Governance of the Nuclear Security Enterprise Dr. Jared Cohon, Co-Chairman, Commission to Review the Effectiveness of the National Energy Laboritories The Honorable TJ Glauthier, Co-Chairman, Commission to Review the Effectiveness of the National Energy Laboritories	Rescheduled	Feb 24, 2016

Meeting	Outbreaks, Attacks, and Accidents: Combatting Biological ThreatsRayburn House Office Building 2123	Canceled	Feb 12, 2016
Hearing	U.S. Public Health Preparedness for Seasonal Influenza: Has the Response Improved?Rayburn House Office Building 232224 documents 4 witnesses Dr. Anne Schuchat, Principal Deputy Director, Centers for Disease Control and Prevention (CDC) Dr. Robin Robinson, Director, Biomedical Advanced Research and Development Authority (BARDA) Dr. Carole Heilman, Director, Division of Microbiology and Infectious Diseases National Institutes of Health (NIH) Dr. Karen Midthun, Director, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)	Scheduled	Nov 19, 2015

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

Congress	Members	Bills referred	Became law	Meetings
119th2025–2026, sitting	20	0	0	11
118th2023–2024	17	0	0	27
117th2021–2022	19	0	0	17
116th2019–2020	19	0	0	21
115th2017–2018	20	0	0	29
114th2015–2016	24	0	0	20
113th2013–2014	27	0	0	17
112th2011–2012	25	0	0	0
111th2009–2010	21	1	1	—
110th2007–2008	17	0	0	—
109th2005–2006	16	0	0	—
108th2003–2004	19	0	0	—
107th2001–2002	17	0	0	—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.